Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction

International Journal of Cardiology

Volumn 202, Issue , 2016, Pages 305-310

  Ahmed, Nadeem ^a,b   Layland, Jamie ^a,b   Carrick, David ^a,b   Petrie, Mark C ^a,b   McEntegart, Margaret ^a,b   Eteiba, Hany ^a,b   Hood, Stuart ^a,b   Lindsay, Mitchell ^a,b   Watkins, Stuart ^a,b   Davie, Andrew ^b   Mahrous, Ahmed ^b   Carberry, Jaclyn ^a   Teng, Vannesa ^a   McConnachie, Alex ^a   Curzen, Nick ^c,d   Oldroyd, Keith G ^a,b   Berry, Colin ^a,b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GOLDEN JUBILEE NATIONAL HOSPITAL   (United Kingdom)

^c UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Adenosine; Blood pressure (BP); Heart rate (HR); Non ST elevation myocardial infarction (NSTEMI); Percutaneous coronary intervention (PCI); ST elevation myocardial infarction (STEMI)

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; VASODILATOR AGENT;

ACUTE HEART INFARCTION; ADENOSINE-INDUCED HYPEREMIA; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; BLOOD PRESSURE MEASUREMENT; BODY MASS; CLINICAL EFFECTIVENESS; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISSECTION; CORONARY ARTERY PRESSURE; CORONARY GUIDE WIRE SENSOR; COUNTERPULSATION; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DIASTOLIC BLOOD PRESSURE; DYSPNEA; FEMALE; FRACTIONAL FLOW RESERVE; HEART FAILURE; HEART INFARCTION; HEART RATE; HEART RUPTURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTRAAORTIC BALLOON PUMP; INTRACORONARY PRESSURE GUIDE WIRE; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR RESISTANCE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; VASCULAR RESISTANCE; CLINICAL TRIAL; CORONARY ANGIOGRAPHY; DRUG EFFECTS; HEMODYNAMICS; MICROCIRCULATION; MIDDLE AGED; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; PHYSIOLOGY; UNITED KINGDOM;

ADENOSINE; CORONARY ANGIOGRAPHY; FEMALE; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HEMODYNAMICS; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDIES; UNITED KINGDOM; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 84960193966     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.09.014     Document Type: Article

References (38)

1. N.H. Pijls, P. van Schaardenburgh, G. Manoharan, E. Boersma, J.W. Bech, M. van't Veer, F. Bär, J. Hoorntje, J. Koolen, W. Wijns, and B. de Bruyne Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study J. Am. Coll. Cardiol. 49 2007 2105 2111
2. P.A. Tonino, B. De Bruyne, N.H. Pijls, U. Siebert, F. Ikeno, M. van' t Veer, V. Klauss, G. Manoharan, T. Engstrøm, K.G. Oldroyd, P.N. Ver Lee, P.A. MacCarthy, W.F. Fearon, and FAME Study Investigators Fractional flow reserve versus angiography for guiding percutaneous coronary intervention N. Engl. J. Med. 360 2009 213 224
3. B. De Bruyne, N.H. Pijls, B. Kalesan, E. Barbato, P.A. Tonino, Z. Piroth, N. Jagic, S. Möbius-Winkler, G. Rioufol, N. Witt, P. Kala, P. MacCarthy, T. Engström, K.G. Oldroyd, K. Mavromatis, G. Manoharan, P. Verlee, O. Frobert, N. Curzen, J.B. Johnson, P. Jüni, W.F. Fearon, and FAME 2 Trial Investigators Fractional flow reserveguided PCI versus medical therapy in stable coronary disease N. Engl. J. Med. 367 2012 991 1001
4. C. Berry, J. Layland, A. Sood, N.P. Curzen, K.P. Balachandran, R. Das, S. Junejo, R.A. Henderson, A.H. Briggs, I. Ford, and K.G. Oldroyd Fractional flow reserve versus angiography in guiding management to optimize outcomes in non-ST-elevation myocardial infarction (FAMOUS-NSTEMI): rationale and design of a randomized controlled clinical trial Am. Heart J. 166 2013 662 668
5. J. Layland, K.G. Oldroyd, N. Curzen, A. Sood, K. Balachandran, R. Das, S. Juneju, N. Ahmed, M. Lee, A. Shaukat, A. O'Donnell, J. Nam, A. Briggs, R. Henderson, A. McConnachie, and C. Berry Fractional flow reserve versus angiography in guiding management to optimise outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial Eur. Heart J. 36 2015 100 111
6. A.R. Payne, C. Berry, O. Doolin, M. McEntegart, M.C. Petrie, M.M. Lindsay, S. Hood, D. Carrick, N. Tzemos, P. Weale, C. McComb, J. Foster, I. Ford, and K.G. Oldroyd Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction J. Am. Heart Assoc. 1 2012 e002246
7. W.F. Fearon, A.F. Low, A.S. Yong, R. McGeoch, C. Berry, M.G. Shah, M.Y. Ho, H.S. Kim, J.P. Loh, and K.G. Oldroyd Prognostic value of the index of microcirculatory resistance measured after primary percutaneous coronary intervention Circulation 127 2013 2436 2441
8. N. Curzen, O. Rana, Z. Nicholas, P. Golledge, A. Zaman, K. Oldroyd, C. Hanratty, A. Banning, S. Wheatcroft, A. Hobson, K. Chitkara, D. Hildick-Smith, D. McKenzie, A. Calver, B.D. Dimitrov, and S. Corbett Does routine pressure wire assessment influence management strategy at coronary angiography for diagnosis of chest pain?: the RIPCORD study Circ. Cardiovasc. Interv. 7 2014 248 255
9. I. Feoktistov, and I. Biaggioni Adenosine A receptors Pharmacol. Rev. 49 1997 381 402
10. L. Belardinelli, J.C. Shryock, Y. Song, D. Wang, and M. Srinivas Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes FASEB J. 9 1995 359 365
11. W. Al Jaroudi, and A.E. Iskandrian Regadenoson: a new myocardial stress agent JACC 54 2009 1123 1130
12. L. Macle, P. Khairy, A. Verma, R. Weerasooriya, S. Willems, T. Arentz, P. Novak, G. Veenhuyzen, C. Scavée, A. Skanes, H. Puererfellner, P. Jaïs, Y. Khaykin, L. Rivard, P.G. Guerra, M. Dubuc, B. Thibault, M. Talajic, D. Roy, S. Nattel, and ADVICE Study Investigators Adenosine following pulmonary vein isolation to target dormant conduction elimination (ADVICE): methods and rationale Can. J. Cardiol. 28 2012 184 190
13. K. Vijayalakshmi, V.J. Whittaker, B. Kunadian, J. Graham, R.A. Wright, J.A. Hall, A. Sutton, and M.A. de Belder Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes Heart 92 2006 1278 1284
14. W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, and D. Taggart Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 31 2010 2501 2555
15. L. Mauri Nonculprit lesions - or guilty by association N. Engl. J. Med. 369 2013 1166 1167
16. FDA Warns of Rare but Serious Risk of Heart Attack and Death with Cardiac Nuclear Stress Test Drugs Lexiscan (Regadenoson) and Adenoscan (Adenosine) http://www.fda.gov/drugs/drugsafety/ucm375654.htm 11-20-2013 Safety Announcement
17. W.F. Fearon, M. Shah, M. Ng, T. Brinton, A. Wilson, J.A. Tremmel, I. Schnittger, D.P. Lee, R.H. Vagelos, P.J. Fitzgerald, P.G. Yock, and A.C. Yeung Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction J. Am. Coll. Cardiol. 51 2008 560 565
18. R. McGeoch, S. Watkins, C. Berry, T. Steedman, A. Davie, J. Byrne, S. Hillis, M. Lindsay, S. Robb, H. Dargie, and K. Oldroyd The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction JACC Cardiovasc. Interv. 3 2010 715 722
19. J. Layland, D. Carrick, M. Lee, K. Oldroyd, and C. Berry Adenosine: physiology, pharmacology, and clinical applications JACC Cardiovasc. Interv. 7 2014 581 591
20. C. Berry The British Heart Foundation Magnetic Resonance Imaging in Myocardial Infarction (MR-MI) Study http://clinicaltrials.gov/ct2/show/NCT02072850
21. P.T. O'Gara, F.G. Kushner, D.D. Ascheim, D.E. Casey Jr., M.K. Chung, J.A. de Lemos, S.M. Ettinger, J.C. Fang, F.M. Fesmire, B.A. Franklin, C.B. Granger, H.M. Krumholz, J.A. Linderbaum, D.A. Morrow, L.K. Newby, J.P. Ornato, N. Ou, M.J. Radford, J.E. Tamis-Holland, C.L. Tommaso, C.M. Tracy, Y.J. Woo, D.X. Zhao, J.L. Anderson, A.K. Jacobs, J.L. Halperin, N.M. Albert, R.G. Brindis, M.A. Creager, D. DeMets, R.A. Guyton, J.S. Hochman, R.J. Kovacs, F.G. Kushner, E.M. Ohman, W.G. Stevenson, and C.W. Yancy American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology 2013
22. NICE: BNF May 2014. Home > 2 Cardiovascular system > 2.3 Anti-arrhythmic drugs > 2.3.2 Drugs for arrhythmias > Supraventricular arrhythmias http://www.evidence.nhs.uk/formulary/bnf/current/2-cardiovascular-system/23-anti-arrhythmic-drugs/232-drugs-for-arrhythmias/supraventricular-arrhythmias/adenosine (Accessed on the 18/05/2013)
23. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, P. Caso, D. Dudek, S. Gielen, K. Huber, M. Ohman, M.C. Petrie, F. Sonntag, M. Sousa-Uva, R. Storey, W. Winjs, and D. Zahger ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur. Heart J. 32 2011 2999 3054
24. Guidelines for Good Clinical Practice in Clinical Trials http://www.mrc.ac.uk/documents/pdf/good-clinical-practice-in-clinical-trials/ 1998
25. K.A. Hicks, H.M.J. Hung, K.W. Mahaffey, Mehran Roxanna, S.E. Nissen, S.L. Stockbridge, S.L. Targum, and R. Temple Standardized Definitions for Cardiovascular and Stroke End Point Events in Clinical Trials Draft Definitions for Testing November 9, 2012 https://www.cardiac-safety.org/think-tanks/ecrf-forms-forposting/Draft%20Definitions%20for%20Testing%20November%209-%202012%20with%20MI%20Preamble%20CLEAN.pdf
26. C.R. Conti Editors note: adenosine: clinical pharmacology and applications Clin. Cardiol. 14 2 1991 91 93
27. S. Shah, D. Parra, and R.S. Rosenstein Acute myocardial infarction during regadenoson myocardial perfusion imaging Pharmacotherapy 33 2013 90 95
28. D.H. Hsi, R. Marreddy, M. Moshiyakhov, and U. Luft Regadenoson induced acute ST-segment elevation myocardial infarction and multivessel coronary thrombosis J. Nucl. Cardiol. 20 2013 481 484
29. A.E. Iskandrian, T.M. Bateman, L. Belardinelli, B. Blackburn, M.D. Cerqueira, R.C. Hendel, H. Lieu, J.J. Mahmarian, A. Olmsted, S.R. Underwood, J. Vitola, and W. Wang Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial J. Nucl. Cardiol. 14 2007 645 658
30. G.S. Thomas, R.C. Thompson, M.I. Miyamoto, T.K. Ip, D.L. Rice, D. Milikien, H.D. Lieu, and V.S. Mathur The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imaging J. Nucl. Cardiol. 16 2009 63 72
31. J.L. Cavalcante, J. Barboza, and K. Ananthasubramaniam Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients J. Nucl. Cardiol. 18 2011 628 633
32. P.K. Nair, O.C. Marroquin, S.R. Mulukutla, S. Khandhar, V. Gulati, J.T. Schindler, and J.S. Lee Clinical utility of regadenoson for assessing fractional flow reserve JACC Cardiovasc. Interv. 4 2011 1085 1092
33. P. Arumugham, V.M. Figueredo, P.B. Patel, and D.L. Morris Comparison of intravenous adenosine and intravenous regadenoson for the measurement of pressure-derived coronary fractional flow reserve EuroIntervention 8 2013 1166 1171
34. F. Cuculi, E. Dall'armellina, C. Manlhiot, A.R. De Caterina, S. Colyer, V. Ferreira, A. Morovat, B.D. Prendergast, J.C. Forfar, N.J. Alp, R.P. Choudhury, S. Neubauer, K.M. Channon, A.P. Banning, and R.K. Kharbanda Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction Eur. Heart J. 35 2013 1971 1980
35. M. Sezer, H. Oflaz, T. Goren, I. Okçular, B. Umman, Y. Nişanci, A.K. Bilge, Y. Sanli, M. Meriç, and S. Umman Intracoronary streptokinase after primary percutaneous coronary intervention N. Engl. J. Med. 356 2007 1823 1834
36. A. Ntalianis, J.W. Sels, G. Davidavicius, N. Tanaka, O. Muller, C. Trana, E. Barbato, M. Hamilos, F. Mangiacapra, G.R. Heyndrickx, W. Wijns, N.H. Pijls, and B. De Bruyne Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction JACC Cardiovasc. Interv. 3 2010 1274 1281
37. M. Marzilli, E. Orsini, P. Marraccini, and R. Testa Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction Circulation 101 2000 2154 2159
38. M. Singh, T. Shah, K. Khosla, P. Singh, J. Molnar, S. Khosla, and R. Arora Safety and efficacy of intracoronary adenosine administration in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials Ther. Adv. Cardiovasc. Dis. 6 2012 101 114